- Home
- KROS vs VVR Comparison
KROS vs VVR Comparison
Compare KROS & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- VVR
- Stock Information
- Founded
- KROS 2015
- VVR 1998
- Country
- KROS United States
- VVR United States
- Employees
- KROS N/A
- VVR N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- KROS Health Care
- VVR Finance
- Exchange
- KROS Nasdaq
- VVR Nasdaq
- Market Cap
- KROS 460.6M
- VVR 588.8M
- IPO Year
- KROS 2020
- VVR N/A
- Fundamental
- Price
- KROS $11.00
- VVR $4.08
- Analyst Decision
- KROS Buy
- VVR
- Analyst Count
- KROS 11
- VVR 0
- Target Price
- KROS $45.33
- VVR N/A
- AVG Volume (30 Days)
- KROS 2.1M
- VVR 692.2K
- Earning Date
- KROS 02-26-2025
- VVR 01-01-0001
- Dividend Yield
- KROS N/A
- VVR 11.38%
- EPS Growth
- KROS N/A
- VVR N/A
- EPS
- KROS N/A
- VVR N/A
- Revenue
- KROS $651,000.00
- VVR N/A
- Revenue This Year
- KROS $303.27
- VVR N/A
- Revenue Next Year
- KROS N/A
- VVR N/A
- P/E Ratio
- KROS N/A
- VVR N/A
- Revenue Growth
- KROS 8037.50
- VVR N/A
- 52 Week Low
- KROS $9.78
- VVR $3.55
- 52 Week High
- KROS $73.00
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- VVR 57.26
- Support Level
- KROS $11.04
- VVR $3.93
- Resistance Level
- KROS $11.99
- VVR $4.14
- Average True Range (ATR)
- KROS 0.60
- VVR 0.06
- MACD
- KROS 1.20
- VVR 0.00
- Stochastic Oscillator
- KROS 43.99
- VVR 69.05
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.